ArticlePublisher preview available

Improvement of activity-related knee joint discomfort following supplementation of specific collagen peptides

Canadian Science Publishing
Applied Physiology Nutrition and Metabolism
Authors:
  • Collagen Research Institute
To read the full-text of this research, you can request a copy directly from the authors.

Abstract and Figures

The aim of the study was to evaluate the use of specific collagen peptides in reducing pain in athletes with functional knee problems during sport. Athletic subjects (n = 139) with functional knee pain ingested 5 g of bioactive collagen peptides (BCP) or a placebo per day for 12 weeks. The primary outcome of the study was a change in pain intensity during activity, which was evaluated by the participants and the attending physicians using a visual analogue scale (VAS). As secondary endpoints, pain intensity under resting conditions, the range of motion of the knee joint, and the use of additional therapeutic options were assessed. The results revealed a statistically significant improvement in activity-related pain intensity in the verum group compared with placebo. (ΔVASBCP = 19.5 ± 2.4; ΔVASPlacebo = 13.9 ± 2.1; p = 0.046). The results were confirmed by the physician’s assessment. (ΔVASBCP = 16.7 ± 1.8; ΔVASPlacebo = 12.2 ± 1.8; p = 0.021). Pain under resting conditions was also improved, but no significance compared with placebo was detected (ΔVASBCP = 10.2 ± 18.4; ΔVASPlacebo = 7.4 ± 15.2; p = 0.209). Due to the high joint mobility at baseline, no significant changes of this parameter could be detected. The use of additional treatment options was significantly reduced after BCP intake. The study demonstrated that the supplementation of specific collagen peptides in young adults with functional knee problems led to a statistically significant improvement of activity-related joint pain.
This content is subject to copyright. Terms and conditions apply.
ARTICLE
Improvement of activity-related knee joint discomfort
following supplementation of specific collagen peptides
Denise Zdzieblik, Steffen Oesser, Albert Gollhofer, and Daniel König
Updated online 18 April 2017: The license for this article has been changed to the CC BY 4.0 license. The PDF and HTML versions
of the article have been modified accordingly.
Abstract: The aim of the study was to evaluate the use of specific collagen peptides in reducing pain in athletes with functional
knee problems during sport. Athletic subjects (n= 139) with functional knee pain ingested5gofbioactive collagen peptides (BCP)
or a placebo per day for 12 weeks. The primary outcome of the study was a change in pain intensity during activity, which was
evaluated by the participants and the attending physicians using a visual analogue scale (VAS). As secondary endpoints, pain
intensity under resting conditions, the range of motion of the knee joint, and the use of additional therapeutic options were
assessed. The results revealed a statistically significant improvement in activity-related pain intensity in the verum group
compared with placebo. (VAS
BCP
= 19.5 ± 2.4; VAS
Placebo
= 13.9 ± 2.1; p= 0.046). The results were confirmed by the physician’s
assessment. (VAS
BCP
= 16.7 ± 1.8; VAS
Placebo
= 12.2 ± 1.8; p= 0.021). Pain under resting conditions was also improved, but no
significance compared with placebo was detected (VAS
BCP
= 10.2 ± 18.4; VAS
Placebo
= 7.4 ± 15.2; p= 0.209). Due to the high joint
mobility at baseline, no significant changes of this parameter could be detected. The use of additional treatment options was
significantly reduced after BCP intake. The study demonstrated that the supplementation of specific collagen peptides in young
adults with functional knee problems led to a statistically significant improvement of activity-related joint pain.
Key words: collagen peptides, collagen hydrolysate, athletes, functional joint discomfort, visual analogue scale.
Résumé : Cette étude a pour objectif d’évaluer l’utilisation de peptides de collagène spécifiques pour la diminution de la douleur
chez des athlètes présentant des anomalies fonctionnelles du genou dans le sport. Cent-trente-neuf athlètes présentant une
douleur fonctionnelle au genou consomment tous les jours5gdepeptides bioactifs de collagène (BCP) ou un placebo durant 12
semaines. Le résultat principal de cette étude est la modification, durant l’activité, de l’intensité de la douleur telle qu’évaluée
par les participants et le médecin sur place au moyen d’une échelle visuelle analogue (VAS). On évalue aussi, dans un deuxième
temps, l’intensité de la douleur au repos, l’amplitude de mouvement du genou et l’utilisation de traitements additionnels. Les
résultats révèlent une diminution statistiquement significative de l’intensité de la douleur a
`l’effort dans le groupe expérimental
comparativement au groupe de contrôle (VAS
BCP
= 19,5 ± 2,4; VAS
Placebo
= 13,9 ± 2,1; p= 0,046). Les résultats confirment
l’évaluation du médecin (VAS
BCP
= 16,7 ± 1,8; VAS
Placebo
= 12,2 ± 1,8; p= 0,021). La douleur au repos est aussi diminuée, mais pas
de façon significative par rapport au groupe de contrôle (VAS
BCP
= 10,2 ± 18,4; VAS
Placebo
= 7,4 ± 15,2; p= 0,209). On n’enregistre
pas de modifications significatives de la mobilité du genou probablement a
`cause de la mobilité élevée de l’articulation au début
de l’expérimentation. À la suite de la consommation de BCP, on note une diminution significative des traitements additionnels.
D’après cette étude, la supplémentation en peptides de collagène spécifiques chez de jeunes adultes présentant des anomalies
fonctionnelles du genou suscite une diminution statistiquement significative de la douleur articulaire associée a
`l’exercice
physique. [Traduit par la Rédaction]
Mots-clés : peptides de collagène, hydrolysat de collagène, athlètes, malaises articulaires fonctionnels, échelle visuelle analogue.
Introduction
Collagen peptides are derived from an enzymatic hydrolysis of
collagen, consisting mainly of the amino acids glycine (Gly), pro-
line (Pro), and hydroxyproline (Hyp) (Clemente 2000;Dybka and
Walczak 2009;Oesser and Seifert 2003;Walrand et al. 2008;
Watanabe-Kamiyama et al. 2010). The amino acids sequence and
the molecular weight distribution of the peptides depends on the
raw materials source and the specific production process (Iwai
et al. 2005;Ohara et al. 2007;Saito et al. 2001). Collagen peptides
are classified as a safe food by the European Food Safety Authority
(European Food Safety Authority 2005) and by the Food and Drug
Administration (FDA (U.S. Food and Drug Administration) 2003). It
has been found that collagen peptides are almost completely re-
sorbed in the small intestine (Iwai et al. 2005;Ohara et al. 2007;
Walrand et al. 2008;Watanabe-Kamiyama et al. 2010). About 10%
of the collagen fragments are taken up in peptide form with a size
of 1 to 10 kDa. These peptides are directly transferred from the
gastrointestinal tract into the blood (Iwai et al. 2005;Ohara et al.
2007;Walrand et al. 2008;Watanabe-Kamiyama et al. 2010). Accord-
ing to the results of preclinical trials, a significant amount of these
peptides accumulate in the articular cartilage (Oesser et al. 1999).
Received 14 July 2016. Accepted 10 January 2017.
D. Zdzieblik. Department of Nutrition, University of Freiburg, Department of Sport and Sport Science, Schwarzwaldstraße 175, 79117 Freiburg,
Germany.
S. Oesser. CRI, Collagen Research Institute, Kiel, Germany, Schauenburgerstraße 116, 24118 Kiel.
A. Gollhofer and D. König. University of Freiburg, Department Sport and Sport Science, Schwarzwaldstraße 175, 79117 Freiburg, Germany.
Corresponding author: Denise Zdzieblik (email: denise.zdzieblik@sport.uni-freiburg.de).
Copyright remains with the author(s) or their institution(s). This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
588
Appl. Physiol. Nutr. Metab. 42: 588–595 (2017) dx.doi.org/10.1139/apnm-2016-0390 Published at www.nrcresearchpress.com/apnm on 24 January 2017.
... Consequently, 4 many individuals experience issues such as wrinkles, loss of skin elasticity, joint stiffness, and decreased bone density, particularly as they age. This has led to growing interest in collagen supplementation as a preventive and therapeutic strategy to improve skin health, joint function, and overall musculoskeletal well-being [19]. Various forms of collagen supplements, such as hydrolyzed collagen, gelatin, and undenatured type II collagen, are widely available, each offering distinct potential benefits [10]. ...
... Beyond structural support, collagen supplementation may modulate the inflammatory phase of wound healing, which, if prolonged, can lead to chronic wounds. Collagen peptides have been shown to reduce levels of pro-inflammatory cytokines such as TNF-α and interleukin-6 (IL-6), creating a more favorable environment for tissue repair [19]. Xu et al. (2019) found that collagen hydrolysates reduced inflammatory markers in UV-damaged skin, suggesting a potential role for collagen in managing inflammatory wounds [7]. ...
... In this population, collagen is valued for its potential to improve muscle recovery, protect joints, and prevent injuries. Research has shown that regular consumption of hydrolyzed collagen can support joint health, which is particularly beneficial for individuals exposed to moderate physical exertion, reducing the risk of joint pain and mobility issues [3,19]. Active individuals, especially those involved in weight-bearing exercises or high-impact activities, often experience joint overload, particularly in the knees, hips, and ankles, which can lead to pain and decreased performance. ...
Article
Full-text available
Collagen, a key structural protein, is essential for maintaining the integrity of connective tissues such as skin, cartilage, tendons, bones. As natural collagen production decreases with age and is further compromised by environmental factors such as UV radiation and poor diet, collagen degradation accelerates, leading to conditions like wrinkles, joint stiffness, and decreased bone density. Collagen supplementation has gained widespread attention as a therapeutic intervention to counteract these effects. This review conducts a comprehensive comparative analysis of various forms of collagen supplementation, including hydrolyzed collagen, undenatured collagen, and gelatin, and their effects on a range of health outcomes. Hydrolyzed collagen, due to enhanced bioavailability, is associated with improvements in skin elasticity, hydration, joint pain relief, and muscle recovery, making it particularly valuable for aging populations and athletes. Undenatured type II collagen, on the other hand, modulates immune responses and shows potential in reducing inflammation and slowing the progression of degenerative joint diseases such as osteoarthritis and rheumatoid arthritis. Gelatin, while less bioavailable than hydrolyzed collagen, still supports skin and joint health when taken in larger quantities. This review also explores emerging evidence of collagen’s beneficial effects on bone density, wound healing, and hair health, with marine-derived collagen showing promise in skin health due to its rapid absorption. Potential adverse effects, including mild gastrointestinal discomfort and rare allergic reactions, are discussed, emphasizing the importance of sourcing high-quality products. Overall, collagen supplementation, particularly hydrolyzed collagen peptides, offers significant therapeutic potential for improving skin, joint, and musculoskeletal health, but further research is required to define optimal dosages, formulations, and long-term safety for various populations.
... Collagen plays a vital role in joint health and cartilage formation and is highly effective in preventing joint pain and progressive cartilage damage over time [24,25]. In addition, it is thought that collagen supplementation may help the treatment of knee injuries with its positive effects on healing and symptom reduction [26]. Many studies have shown that collagen supplementation is effective in treating degenerative joint disorders and reduces pain symptoms [27][28][29][30]. ...
... The scale consists of 14 questions that evaluate fall risk and loss of balance. Each item is scored between 0 and 4. The scores are evaluated as high fall risk (0-20), moderate fall risk (21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40), and low fall risk (41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53)(54)(55)(56). A standard chair, a standard step, a 15-m corridor, and a stopwatch were used for the Test. ...
Article
Full-text available
Background Menisci, one of the most important anatomical structures of the knee joint, plays a role in load transfer, stability, shock absorption, prevention of articular cartilage degeneration, and proprioception. Type I collagen, the main component of the meniscus, and type II collagen fibers play an important role in the stability of the knee joint. This study aimed to evaluate the effects of Naturagen® 4 Joint product containing type I, II, and III collagen on pain, quality of life, and physical functions in patients with meniscopathy. Methods This randomized, double-blind, placebo-controlled clinical study included 32 patients (collagen = 17 and placebo = 15) with meniscopathy. Patients completed the Visual Analog Scale (VAS), Western Ontario and McMaster Universities Osteoarthrtis Index (WOMAC), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Oxford Knee Score (OKS), Tampa Scale for Kinesiophobia (TSK), Short Form Health Survey (SF-12), Lower Extremity Functional Scale (LEFS), Foot Function Index (FFI), proprioceptive sensation, Timed Up and Go (TUG), 6-Minute Walking Test (6MWT), The Five Repetition Sit to Stand Test (5STS), Stair Climbing Test (SCT), Berg Balance Scale (BBS) and back and leg strength tests and scales were applied. All tests were repeated before and after eight weeks of collagen supplementation. Results The study showed that eight weeks of supplementation with various collagen types had statistically significant effects on pain, quality of life, kinesiophobia, and foot function scale scores in patients with meniscopathy (p < 0.05). Similarly, eight weeks of supplementation showed a statistically significant difference in leg strength (p = 0.057), but no significant difference was found in back strength, proprioception, balance, and various functional test results (p > 0.05). Conclusions The results of the study showed that the eight-week collagen-based supplement had a positive effect on pain and quality of life levels and some functional test results in patients with meniscopathy. Longer-term studies and diversification of subject groups will help to understand better the effects of the product on meniscal tears and symptoms. Trial registration The study was retrospectively registered in the Iranian Clinical Trials Registry on 14/05/2024 with the number IRCT20240411061470N2.
... The hydrolysis process significantly enhances the solubility, bioavailability and functional properties of collagen [17]. Currently, hydrolyzed collagen has gained considerable popularity due to its potential benefits in promoting joint health [18], improving skin elasticity [19,20] and enhancing wound healing, particularly in the early stages of the repair process [15]. ...
Article
Full-text available
Collagen proteins play important roles in wound healing and are of great interest in regenerative medicine. This study evaluated the efficacy of new collagen‐based products and compared them to commercial products in a murine model of cutaneous healing. Circular excisional defects were generated on 72 Wistar rats. Six study groups were established according to the administered collagen treatment: Control (without treatment), SD‐C (semidenatured), Catrix, Hy‐C (hydrolyzed), N‐C (native) and Helix3‐CP. Seven and eighteen days post‐surgery, animals were euthanized. Wound closure was macroscopically assessed by taking zenithal images of the defects. Morphological, histological and immunohistochemical studies were performed to evaluate the healing process. After 7 days, open areas and degree of epithelialization were similar among the groups. Significant differences were observed in contraction between control and the N‐C and Helix3‐CP groups. Untreated animals exhibited a more pronounced granulation tissue with a high number of inflammatory cells and a disorganised extracellular matrix with type III collagen deposition. After 18 days, animals treated with new collagen (Hy‐C and N‐C) exhibited accelerated wound closure, increased epithelialization and a more organised granulation tissue. Local administration of new collagen treatments promotes the progression of the reparative process and significantly accelerates wound closure compared with nontreated wounds.
... In mammals, collagen protein is highly abundant and mainly localized in the ECM of fibrous connective tissues, such as the tendon and skin [7][8][9][10]. It plays key structural roles by supporting the formation, tensile strength, and flexibility of joints [11][12][13][14][15]. Collagen types I, II, III, V, and XI are able to form fibrils that are necessary for structural support and resistance to mechanical stress in connective tissues [16,17]. ...
Article
Full-text available
It is evident that marine collagen in collafibe sachets is a versatile compound capable of healing skin injuries of varying severity, as well as delaying the natural human aging process. From in vitro to in vivo experiments, collagen has demonstrated its ability to invoke keratinocyte and fibroblast migration as well as vascularization of the skin. Additionally, marine collagen and derivatives have proven beneficial and useful for both osteoporosis and osteoarthritis prevention and treatment. Other bone-related diseases may also be targeted by collagen, as it is capable of increasing bone mineral density, mineral deposition, and importantly, osteoblast maturation and proliferation. Marine organisms harbor numerous bioactive substances .Scientific research on various applications of collagen extracted from these organisms has become increasingly prevalent. Marine collagen in collafibe sachets can be used as a biomaterial because it is water soluble, metabolically compatible, and highly accessible. The present Article Reviews the role of collafibe sachets in Improving cell turnover and collagen formation, which keeps your skin stay elastic and healthy.
... These findings from a study also implies that, when degenerative joint disease is not present, 5 g per day COL may be just as beneficial as 10 g per day COL in reducing discomfort while exercising for athletes 81 . Collagen type I, II and IV , proteoglycan, and elastin synthesis are increased by COL in the cartilage of the joints, which may lessen tissue injury and alleviate pain. ...
Article
Full-text available
The most prevalent protein in the human body, collagen is essential for preserving the structural soundness and functionality of different tissues. It is an essential part of connective tissues, which include skin, cartilage, bones, tendons, and ligaments. It also plays a key role in wound healing, cell signaling, and tissue repair. The many functions of collagen in human health and its connections to different illnesses are examined in this overview. It looks at the biochemical and structural characteristics of the many forms of collagen, the processes by which collagen is synthesized and broken down, and how imbalances can result in diseases including cardiovascular problems, fibrosis, osteoarthritis, and skin aging. There is also discussion of new treatment options, such as supplements, collagen-based biomaterials, and regenerative medicine techniques. New treatments targeted at promoting tissue repair, boosting quality of life, and avoiding collagen-related illnesses may be made possible by a better understanding of the many roles that collagen plays in both health and disease.
... Despite the well-established relationship between exercise stimulus/loading and collagen synthesis [21,22], research on the role of supplements that support these adaptations is in its early stages. Clinical trials [23,24] showed improved joint pain in athletes who complained about joint pain or discomfort and were treated with the dietary supplement CH. Recent studies [25,26] showed that vitamin C-enriched CH supplementation had a promising effect on the recovery of jumpers' knees and improved the rate of force development in the squat and counter-movement jump alongside training. ...
Article
Full-text available
The use of dietary supplements is widespread in sports and fitness, with many products containing multiple ingredients. Among supplements often consumed to support musculotendinous health, collagen hydrolysate (CH) has gained popularity for its potential in improving joint comfort and function. This single-blind quasi-experimental study investigated the effects of a three-month oral supplementation with a specific CH-based product, Chondrovita FIT® (Bone Srl, Rome, Italy), on tendon structure in elite Italian skaters. Eighteen male and female elite skaters (mean age: 21 ± 3 years) participated, receiving daily pre-workout (4500 mg CH) and post-workout (2500 mg CH) doses. Tendon structure in the patellar and peroneal tendons was assessed using ultrasound imaging at baseline and post-supplementation. Results showed a significant increase in tendon thickness in both the patellar and peroneal tendons after supplementation, although no changes were observed in the tendon cross-sectional area. These findings suggest that Chondrovita FIT® supplementation may induce beneficial structural changes in tendons, potentially supporting tendon health and performance in high-load sports. However, further research is needed to confirm long-term effects and functional outcomes.
... Moreover, marine organisms have abundant collagen resources and low prices, which are widely found in more than 20 million tons of byproducts, such as fish skin, heads, fins, and viscera [104]. Collagen, an important structural protein in the animal ECM and connective tissue, plays an important role in supporting the formation, tensile strength, and flexibility of joints [105][106][107][108]. Marine collagen can also reduce wrinkles, improve skin elasticity, and enhance the overall structure and appearance of the skin. ...
Article
Full-text available
The skin is the first line of defense to protect the host from external environmental damage. When the skin is damaged, the wound provides convenience for the invasion of external substances. The prolonged nonhealing of wounds can also lead to numerous subsequent complications, seriously affecting the quality of life of patients. To solve this problem, proteins and peptide components that promote wound healing have been discovered in animals, which can act on key pathways involved in wound healing, such as the PI3K/AKT, TGF-β, NF-κ B, and JAK/STAT pathways. So far, some formulations for topical drug delivery have been developed, including hydrogels, microneedles, and electrospinning nanofibers. In addition, some high-performance dressings have been utilized, which also have great potential in wound healing. Here, research progress on the promotion of wound healing by animal-derived proteins and peptide components is summarized, and future research directions are discussed.
Article
Introduction Musculoskeletal discomfort is prevalent in primary care, with conditions such as osteoarthritis and osteoporosis being significant contributors. Collagen, particularly type I, is a major structural protein found in connective tissues. The supplementation of type I hydrolyzed collagen has been investigated for its potential benefits in musculoskeletal health. Objective This systematic review aims to evaluate the current literature on the effects of type I hydrolyzed collagen supplementation on bones, muscles, and joints. Methods A systematic search was conducted in August 2024 using four electronic databases - PubMed, Scopus, EMBASE, and CINAHL. The inclusion criteria were randomized controlled trials (RCTs) and systematic reviews evaluating oral supplementation with type I hydrolyzed collagen. Exclusion criteria were pre-clinical studies, experimental studies, studies not focusing on type I hydrolyzed collagen, studies with beauty-related endpoints, studies that combined collagen with other ingredients, and unblinded, nonrandomized, and uncontrolled trials. Results Out of 4,246 articles screened, 36 RCTs met the inclusion criteria. The study protocols varied in population, health conditions, and study duration. Studies focused on bone health faced limitations that prevent definitive conclusions about the effects of collagen supplementation. In contrast, studies on joint health reported beneficial outcomes, such as pain reduction, improvements in clinical parameters, increased physical mobility, and enhanced ankle function. The muscle health studies were inconsistent, with positive effects predominantly observed when supplementation was associated with physical exercise. Conclusion Collagen supplementation demonstrates promising results. However, heterogeneity among studies limits the generalizability of findings. Future research should prioritize standardized protocols and consistent outcome measures.
Article
Full-text available
To evaluate in an interventional trial on knee osteoarthritis (OA) the level and change of two serum biomarkers and their correlation with imaging parameters. The previously reported interventional OA study (ClinicalTrials.gov: NCT00536302) identified a positive effect of collagen hydrolysate (CH) on cartilage morphology in patients with knee OA using delayed gadolinium enhanced magnetic resonance imaging (dGEMRIC). It was the objective in this research project to evaluate in an interventional clinical trial on knee OA the level and change of two serum biomarkers and their correlation with imaging parameters. In blood samples of study participants, we determined the concentration of procollagen type II N-terminal propeptide (PIIANP) and aggrecan chondroitin sulfate 846 epitope (CS846) at baseline (BL) and at the follow-up (FU) visits at 24 and 48 weeks. We measured the level and change of biomarker concentrations in both study groups, and the correlation of those changes with changes in dGEMRIC. For the biomarker PIIANP, we observed a significantly greater increase in the CH group (29.9% vs. 1.2% at week 24, P = 0.001). For CS846, the mean concentration was lower among the CH treated participants at 24 weeks (78% vs. 96%, P = 0.045). Consistent correlations of changes in biomarkers PIIANP and CS846 with changes of the dGEMRIC score could not be observed. In this study, different changes per treatment group, CH and placebo were seen for dGEMRIC and PIIANP BL to 24 weeks FU, but only weak correlations between changes in dGEMRIC and biochemical markers.
Article
Full-text available
Paper reviews literature data connected with properties of collagen hydrolysates applied as diet supplements. Biological and health promoting activity of collagen derived peptides has been well documented in many studies, especially for the therapeutical treatment of bones and joints diseases as well as for the improvement of skin, hair and nails conditon. High tolerance of patients for long-term ingested collagen hydrolysates make them attractive for use as health promoting diet supplement.
Article
Full-text available
BACKGROUND: Recent studies show that enzymatically hydrolyzed collagen, the collagen peptide is absorbed and distributed to joint tissues and has analgesic and anti-inflammatory properties. A double blind placebo controlled randomized trial with collagen peptides isolated from pork (PCP) and bovine bone (BCP) sources was carried out to study the effectiveness of orally supplemented collagen peptide to control the progression of osteoarthritis in patients diagnosed with knee osteoarthritis. Improvement in treatment was assessed with reduction in Western Ontario McMaster Universities (WOMAC), visual analogue scale (VAS) and Quality of Life (QOL) scores from baseline to 13 weeks (Visit 7). Safety and tolerability were also evaluated. RESULTS: There was significant reduction from base line to Visit 7 in the primary end points of WOMAC and VAS scores and in the secondary end point of QOL score in subjects with PCP and BCP groups, while in subjects with placebo group the end point indices remained unaltered. Furthermore, all the score levels of WOMAC, VAS and QOL decreased significantly (p < 0.01) in study group compared to placebo group in Visit 7. CONCLUSION: The study demonstrated that the collagen peptides are potential therapeutic agents as nutritional supplements for the management of osteoarthritis and maintain joint health.
Article
Full-text available
Patellofemoral pain (PFP) is often seen in physically active individuals and may account for 25-40% of all knee problems seen in a sports injury clinic.1 ,2 Patellofemoral-related problems occur more frequently in women than in men.3 PFP is characterised by diffuse pain over the anterior aspect of the knee and aggravated by activities that increase patellofemoral joint (PFJ) compressive forces, such as squatting, ascending and descending stairs and prolonged sitting, as well as repetitive activities such as running. It, therefore, has a debilitating effect on sufferers’ daily lives by reducing their ability to perform sporting and work-related activities pain free. Dye has described PFP as an orthopaedic enigma, and it is one of the most challenging pathologies to manage.4 Alarmingly, a high number of individuals with PFP have recurrent or chronic pain.5 While physiotherapy interventions for PFP have proven effective compared with sham treatments, treatment results can be disappointing in a proportion of patients. This variability in treatment results may be due to the fact that the underlying factors that contribute to the development of PFP are not being addressed, or are not the same for all patients with PFP. The mission of the 3rd International Patellofemoral Research Retreat was to improve our understanding concerning the factors that contribute to the development and consequently to the treatment of PFP. The 3rd International Patellofemoral Research Retreat was held in Vancouver, Canada, in September 2013, for 3 days: from 18 September to 21 September. After peer-review for scientific merit and relevance to the retreat, 58 abstracts were accepted for the retreat (39 podiums, 8 posters and 11 thematic posters). The podium and poster presentations were grouped into three categories: (1) natural history of PFP and local factors that influence PFP, (2) trunk and distal factors that influence PFP and …
Article
Full-text available
Protein hydrolysates constitute an alternative to intact proteins and elemental formulas in the development of special formulations designed to provide nutritional support to patients with different needs. The production of extensive protein hydrolysates by sequential action of endopeptidases and exoproteases coupled with the development of post-hydrolysis procedures is considered the most effective way to obtain protein hydrolysates with defined characteristics. This paper reviews the development and use of protein hydrolysates for dietary treatment of patients with phenylketonuria, food allergy and chronic liver failure.
Article
Objective To assess the effects of physical exercise on physical, functional and psychological dimensions in nursing home residents.